Literature DB >> 21059492

Regression of stroke-like lesions in MELAS-syndrome after seizure control.

Josef Finsterer1, Peter Barton.   

Abstract

There are some indications that seizure activity promotes the development of stroke-like episodes, or vice versa, in patients with mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome or other syndromic mitochondrial disorders. A 41-year-old Caucasian female with MELAS syndrome, presenting with short stature, microcytic anaemia, increased blood-sedimentation rate, myopathy, hyper-gammaglobulinaemia, an iron-metabolism defect, migraine-like headaches, and stroke-like episodes, developed complex partial and generalised seizures at age 32 years. Valproic acid was ineffective but after switching to lamotrigine and lorazepam, she became seizure-free for five years and stroke-like episodes did not recur. Cerebral MRI initially showed enhanced gyral thickening and a non-enhanced T2-hyperintensity over the left parieto-temporo-occipital white matter and cortex and enhanced caudate heads. After two years without seizures, the non-enhanced hyperintense parieto-temporo-occipital lesion had disappeared, being attributed to consequent seizure control. The caudate heads, however, remained hyperintense throughout the observational period. This case indicates that adequate seizure control in a patient with MELAS syndrome may prevent the recurrence of stroke-like episodes and may result in the disappearance of stroke-like lesions on MRI.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21059492     DOI: 10.1684/epd.2010.0338

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN: 1294-9361            Impact factor:   1.819


  6 in total

Review 1.  Imaging of MELAS.

Authors:  Konark Malhotra; David S Liebeskind
Journal:  Curr Pain Headache Rep       Date:  2016-09

2.  Migraine prophylaxis, ischemic depolarizations, and stroke outcomes in mice.

Authors:  Katharina Eikermann-Haerter; Jeong Hyun Lee; Nilufer Yalcin; Esther S Yu; Ali Daneshmand; Ying Wei; Yi Zheng; Anil Can; Buse Sengul; Michel D Ferrari; Arn M J M van den Maagdenberg; Cenk Ayata
Journal:  Stroke       Date:  2014-11-25       Impact factor: 7.914

Review 3.  Neuroimaging in mitochondrial disorders.

Authors:  Andrea L Gropman
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

4.  Stroke and Stroke-like Episodes in Muscle Disease.

Authors:  Josef Finsterer
Journal:  Open Neurol J       Date:  2012-05-18

5.  Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells.

Authors:  Nicole Min Qian Pek; Qian Hua Phua; Beatrice Xuan Ho; Jeremy Kah Sheng Pang; Jin-Hui Hor; Omer An; Henry He Yang; Yang Yu; Yong Fan; Shi-Yan Ng; Boon-Seng Soh
Journal:  Cell Death Dis       Date:  2019-10-22       Impact factor: 8.469

Review 6.  Review: Central nervous system involvement in mitochondrial disease.

Authors:  N Z Lax; G S Gorman; D M Turnbull
Journal:  Neuropathol Appl Neurobiol       Date:  2016-07-07       Impact factor: 8.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.